Aytu Biopharma (AYTU) Cash & Equivalents (2011 - 2026)
Aytu Biopharma's Cash & Equivalents was $26.31 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 15.0% from $30.95 million a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Cash & Equivalents (2011 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, Aytu Biopharma has reported Cash & Equivalents for 55 quarters.
- Cash & Equivalents shows a five-year compound annual growth rate of -12.0% (FY2021 to FY2026).
- In earlier fiscal years, Cash & Equivalents was $30.95 million in FY2025 (+54.7%), $20.01 million in FY2024 (-13.0%), $22.99 million in FY2023 (+18.7%) and $19.36 million in FY2022 (-61.2%).
- The fiscal Q4 2026 figure marks the lowest quarterly Cash & Equivalents since fiscal Q3 2025.
- Compared with a year earlier, Cash & Equivalents was higher in six of the last eight quarters, with growth averaging 24.2%.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q1 2026 (growth of 62.3%); the worst was fiscal Q4 2022 (a decline of 61.2%).
- Per Business Quant data, AYTU's Cash & Equivalents in the three fiscal quarters before Q4 2026 was $26.72 million (Q3 2026), $30.03 million (Q2 2026) and $32.63 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | 26.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.31 Mn |
| Mar 31, 2026 | 26.72 Mn |
| Dec 31, 2025 | 30.03 Mn |
| Sep 30, 2025 | 32.63 Mn |
| Jun 30, 2025 | 30.95 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Dec 31, 2024 | 20.40 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 20.01 Mn |
| Mar 31, 2024 | 19.76 Mn |
| Dec 31, 2023 | 19.53 Mn |
| Sep 30, 2023 | 19.96 Mn |
| Jun 30, 2023 | 22.99 Mn |
| Mar 31, 2023 | 19.18 Mn |
| Dec 31, 2022 | 19.50 Mn |
| Sep 30, 2022 | 23.81 Mn |
| Jun 30, 2022 | 19.36 Mn |
| Mar 31, 2022 | 27.61 Mn |
| Dec 31, 2021 | 35.28 Mn |
| Sep 30, 2021 | 40.31 Mn |
API Access
Aytu Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();